8:01 am Bristol-Myers Squibb submits NDAs for Daclatasvir and Asunaprevir to US FDA for the treatment of Hepatitis C
View todays social media effects on BMY
View the latest stocks trending across Twitter. Click to view dashboard
See who Bristol is hiring next, click here to view
